CSL's Financial Results
CSL's annual profit and final dividend announcement for 2018/19 was announced on 14th August 2019. Please click to view our historic Full Year and Half Year Financial Results.More Information
Search Results87 results found
We will announce our 2019 Full Year Results on Wednesday, 14th August 2019 (AEST)
CSL Limited have announced 2018 Full Year Results for the period ending 30 June 2018. Full details available here.
CSL Limited is a global biotechnology manufacturer that researches, develops, and markets products to treat and prevent rare and serious diseases. Learn more.
CSL Limited 2019 Full Year Results Paul Perreault, CEO and MD 14 August 2019 David Lamont, CFO LEGAL NOTICE
On-market purchases under the plan were made twice yearly, following the announcement of CSL's half and full year results Additional shares may be purchased by NEDs on-market at prevailing share prices in accordance with CSL's Securities Dealing Policy
2018 Full Year Results 15 August 2018
On-market purchases under the plan were made twice yearly, following the announcement of CSL's half and full year results Additional shares may be purchased by NEDs on-market at prevailing share prices in accordance with CSL's Securities Dealing Policy Post-Employment Benefits Superannuation contributions are made in accordance with legislation and are included in the reported base fee, and are not additional to the base fee.
ASX Announcement Full Year Results 2017
ASX Full-year information 30 June 2017
ASX Announcement Full Year Result 2016